Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Interleukin-34 restores blood-brain barrier integrity by upregulating tight junction proteins in endothelial cells.
Reduced grey matter perfusion without volume loss in early relapsing-remitting multiple sclerosis.
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.
[Research progresses of monoclonal antibodies therapy in neuromyelitis optica].
Acute Disseminated Encephalomyelitis (ADEM)-A Rare Complication of Falciparum Malaria.
A gene pathway analysis highlights the role of cellular adhesion molecules in multiple sclerosis susceptibility.
Cell-specific effects in different immune subsets associated with SOCS1 genotypes in multiple sclerosis.
In vivo evidence of a functional association between immune cells in blood and brain in healthy human subjects.
Disease-modifying therapies and infectious risks in multiple sclerosis.
Efficacy of lower fingolimod doses in the treatment of MS.
Functional organization of an Mbp enhancer exposes striking transcriptional regulatory diversity within myelinating glia.
[Pharmaceutical prescription for multiple sclerosis : Evaluation of pharmaceutical consumption at private health insurance.]
Age-Dependent Decline of Nogo-A Protein in the Mouse Cerebrum.
Computer-based diagnosis of illness in historical persons.
Off-pump coronary surgery in a patient with multiple sclerosis.
Lymphomatoid papulosis: A cutaneous lymphoproliferative disorder in a patient on fingolimod for multiple sclerosis.
Nogo Receptor Inhibition Enhances Functional Recovery following Lysolecithin-Induced Demyelination in Mouse Optic Chiasm.
A case of acute combined central and peripheral demyelination.
Multiple sclerosis decreases explicit counterfactual processing and risk taking in decision making.
MRI measures should be a primary outcome endpoint in phase III randomized controlled trials in multiple sclerosis: No.
Vitamin D immunomodulatory potential in multiple sclerosis.
Response to letter regarding article 'Fingolimod effects on left ventricular function in multiple sclerosis'.
Reliability of Longitudinal Brain Volume Loss Measurements between 2 Sites in Patients with Multiple Sclerosis: Comparison of 7 Quantification Techniques.
Molecular network of chromatin immunoprecipitation followed by deep sequencing-based vitamin D receptor target genes.
Differential microRNA expression in blood in multiple sclerosis.
Pages
« first
‹ previous
…
339
340
341
342
343
344
345
346
347
…
next ›
last »